In line with the recent advancement in immunotherapies, Yu et al. showed 40% PD-L1 positivity in their tumour cohort with an associated increase in PD1+ and CD8+ lymphocyte infiltration in the tumour and stroma. Here, CD8A is linked to neoplasm.